EUVIMEDEUVIMED entdecken
CrossrefInfokarte

In silico analysis of SCO, an almost undescribed family of β-lactamases

Joaquim Ruiz

Revista Española de Quimioterapia · 2026-10-21 · 39 (6)

DOI: 10.37201/req/241.2026 ↗
AbstractBibliografische Angaben

Abstract

Introduction: β-lactamases rank amongst the most common mechanisms of antibiotic resistance, accounting for thousands of different variants. Current genomic tools have resulted in an exponential growth of new variants, most of which, as is the case for SCO, remain undescribed or non-characterised. This study aimed to detect new variants of SCO in GenBank records. Material and methods: The amino acid sequence of SCO-1 was compared with what is present in GenBank. Only amino acid sequences with >85% identity were considered. No synthetic or partial sequences were included in the analyses. Results: Eleven different SCO variants were detected, 9 of which had previously not been designated as specific variants. Several of the modifications suggested the possible expansion of substrates towards 3rd and 4th generation cephalosporins or the resistance to inhibitors, while others might impair SCO functionality. SCO β-lactamases were detected in 6 bacterial families accounting for 14 genera. Conclusions: The presence of undescribed SCO variants in GenBank is reported, and the need to establish the exact substrate profile of new variants is highlighted.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →